During the past decade, Complejo Hospitalario Ruber Juan Bravo conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 3 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario Ruber Juan Bravo" #1 sponsor was "MedSIR" with 7 trials, followed by "PETHEMA Foundation" with 5 trials sponsored, "Biogen" with 3 trials sponsored, "Araclon Biotech S.L." with 1 trials sponsored and "BioInvent International AB" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Ruber Juan Bravo" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Ruber Juan Bravo" are "Alzheimer's Disease" (3 trials), "Triple Negative Breast Cancer" (3 trials), "Breast Cancer Metastatic" (2 trials), "Multiple Myeloma" (2 trials) and "Osteoporosis" (2 trials). Many other conditions were trialed in "Complejo Hospitalario Ruber Juan Bravo" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Ruber Juan Bravo" are "Drug" (25 trials), "Biological" (3 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "1L PEG + ASCORBIC ACID" (1 trials), "ABvac40" (1 trials), "ATRA" (1 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Ruber Juan Bravo" are 25 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Hospitalario Ruber Juan Bravo". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Complejo Hospitalario Ruber Juan Bravo, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Ruber Juan Bravo, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Complejo Hospitalario Ruber Juan Bravo has several departments that took part in Clinical trials: "Clinica Ruber, 4 planta; Servicio de Neurologia" - 3 trials